-+ 0.00%
-+ 0.00%
-+ 0.00%

Sutro Biopharma Q3 EPS $(0.67) Misses $(0.41) Estimate, Sales $9.693M Beat $9.132M Estimate

Benzinga·11/06/2025 22:00:07
Listen to the news
Sutro Biopharma (NASDAQ:STRO) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.41) by 65.02 percent. This is a 13.56 percent decrease over losses of $(0.59) per share from the same period last year. The company reported quarterly sales of $9.693 million which beat the analyst consensus estimate of $9.132 million by 6.15 percent. This is a 13.77 percent increase over sales of $8.520 million the same period last year.